Chromosome arm 17p13.3: Could hic1 be the one?;HIC1: Le nœud du problème en 17p13.3?

Medecine/Sciences

Volumn 22, Issue 1, 2006, Pages 54-61

  Chopin, Valérie ^a   Leprince, Dominique ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE DEACETYLASE; PROTEIN HIC1; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HIC1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ALLELE; BREAST CANCER; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME 17P; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SILENCING; HETEROZYGOSITY LOSS; HIC1 GENE; HUMAN; LUNG SMALL CELL CANCER; MEDULLOBLASTOMA; MILLER DIEKER SYNDROME; NONHUMAN; OVARY CANCER; OVCA1 GENE; PROTEIN DOMAIN; REPRESSOR GENE; REVIEW; SOLID TUMOR; TELOMERE; TUMOR SUPPRESSOR GENE; ZINC FINGER MOTIF; ANIMAL; CHROMOSOME 17; CHROMOSOME MAP; DISEASE MODEL; GENETIC MARKER; GENETICS; METABOLISM; MOUSE; NEOPLASM;

ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENETIC MARKERS; HISTONE DEACETYLASES; HUMANS; LOSS OF HETEROZYGOSITY; MICE; NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 31144463647     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200622154     Document Type: Review

References (30)

1. Feinberg AP. The epigenetics of cancer etiology. Sem Cancer Biol 2004; 14: 427-32.
2. Wales MM, Biel MA, El-Deiry W, et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995; 1: 570-7.
3. Schultz DC, Vanderveer L, Berman DB, et al. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 1996; 56: 1997-2002.
4. Pinte S, Stankovic-Valentin N, Deltour S, et al. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J Biol Chem 2004; 279: 38313-24.
5. Deltour S, Pinte S, Guerardel C, et al. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol Cell Biol 2002; 22: 4890-901.
6. Prive GG, Melnick A, Ahmad K, Licht JD. Zinc finger proteins: from atomic contact to cellular function, In: Iuchi S, Kuldell N, eds. Georgetown: Landes Biosciences, 2004.
7. Deltour S, Guerardel C, Leprince D, Recruitment of SMRT/N-CoR-mSm3A-HDAC- repressmg complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc Natl Acad Sci USA 1999; 96: 14831-6.
8. Yang XJ, Gregoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 2005; 25: 2873-84.
9. Yamanaka M, Watanabe M, Yamada y, et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003; 106: 382-7.
10. Kanai Y, Ushijima S, Ochiai A, et al. DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett 1998; 122: 135-41.
11. Pieretti M, Powell DE, Gallion HH, et al. Hypermethylation at a chromosome 17 «hot spot» is a common event in ovarian cancer. Hum Pathol 1995; 26: 398-401.
12. Fujii H, Biel MA, Zhou W, et al. Methyiation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 1998; 16: 2159-64.
13. Rood BR, Zhang H, Weitman DM, Cogen PH. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 2002; 62: 3794-7.
14. Chen WY, Zeng X, Carter MG, et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 2003; 33: 197-202.
15. Kwabi-Addo B, Giri D, Schmidt K, et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 2001; 98: 11563-8.
16. DePinho RA. The age of cancer. Nature 2000; 408: 248-54.
17. Quon KC, Berns A. Haplo-insufficiency? Let me count the ways. Genes Dev 2001; 15: 2917-21.
18. Wynshaw-Boris A, Gambello MJ. LIS1 and dynein motor function in neuronal migration and development. Genes Dev 2001; 15: 639-51.
19. Cardoso C, Leventer RJ, Ward HL, et al. Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet 2003; 72: 918-30.
20. Carter MG, Johns MA, Zeng X, et al. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum Mol Genet 2000; 9: 413-9.
21. Grimm C, Sporle R, Schmid TE, et al. Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome. Hum Mol Genet 1999; 8: 697-710.
22. Chen CM, Behringer RR. Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev 2004; 18: 320-32.
23. Chen W, Cooper TK, Zahnow CA, et al. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 2004; 6: 387-98.
24. Britschgi C, Rizzi M, Grob TJ, et al. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 2005; november 21 (online).
25. Guerardel C, Deltour S, Pinte S, et al. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J Biol Chem 2001; 276: 3078-89.
26. Chen W, Wamng DH, Yen RC, et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53 dependent DNA damage responses. Cell 2005; 123: 437-48.
27. Vaziri H, Dessain SK, Ng-Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-59.
28. Senawong T, Peterson VJ, Leid M. BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. Arch Biochem Biophys 2005; 434: 316-25.
29. Chen WY, Baylin SB. Inactivation of tumor suppressor genes: choice between genetic and epigenetic routes. Cell Cycle 2005; 4: 10-2.
30. Nicoll G, Crichton DN, McDowell HE, et al. Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer 2001; 85: 1878-82.